Elicio Therapeutics, Inc. (ELTX)
NASDAQ: ELTX · Real-Time Price · USD
1.500
-0.090 (-5.66%)
At close: Nov 19, 2026, 4:00 PM EST
1.450
-0.050 (-3.33%)
After-hours: Nov 19, 2026, 7:30 PM EST
Elicio Therapeutics Market Cap
Elicio Therapeutics has a market cap or net worth of $42.46 million as of November 19, 2026. It is the 31,117th most valuable company in the world and the 4,650th biggest in the United States. Its market cap has decreased by 71.65% in one year.
Market Cap
42.46M
Enterprise Value
25.55M
1-Year Change
-71.65%
Global Rank
Country Rank
#4,650 United States
Category
ChartMarket Cap Chart
Since June 2, 2023, Elicio Therapeutics's market cap has decreased from $312.21M to $42.46M, a decrease of -86.40%. That is a compound annual growth rate of -43.74%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 19, 2026 | 42.46M | -69.47% |
| Dec 31, 2025 | 139.10M | 153.09% |
| Dec 31, 2024 | 54.96M | -31.39% |
| Dec 29, 2023 | 80.11M | -74.34% |
| Jun 2, 2023 | 312.21M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| ImageneBio | 44.27M |
| Mereo BioPharma Group | 43.84M |
| MindWalk Holdings | 42.72M |
| Actinium Pharmaceuticals | 42.45M |
| Aldeyra Therapeutics | 41.88M |
| Dogwood Therapeutics | 41.29M |
| Pliant Therapeutics | 40.88M |
| IRulya Therapeutics | 39.11M |